EMA — authorised 28 September 2012
- Marketing authorisation holder: Novartis Europharm Limited
- Status: approved
🇪🇺 Cuvposa in European Union
EMA authorised Cuvposa on 28 September 2012
Marketing authorisation
Cuvposa in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in European Union
Frequently asked questions
Is Cuvposa approved in European Union?
Yes. EMA authorised it on 28 September 2012.
Who is the marketing authorisation holder for Cuvposa in European Union?
Novartis Europharm Limited holds the EU marketing authorisation.